Pharma channel feed

GSK CEO Em­ma Walm­s­ley on the new Trump ad­min­is­tra­tion, trust, AI and Chi­na

6 months ago
People
China

CVS names Aet­na head, plans more phar­ma­cy clo­sures as new CEO takes over

6 months ago
People
Health Tech

No­vo un­veils new car­diometa­bol­ic da­ta as it re­ports sol­id third-quar­ter prof­its

6 months ago
R&D

Aca­dia lands $150M sale of rare pe­di­atric PRV

6 months ago
FDA+

‘We’re good’ on weight loss: Bio­phar­mas turn to mus­cle with new obe­si­ty drugs

6 months ago
Startups
R&D

Cere­bral to pay near­ly $3.7M over con­trolled sub­stance pre­scrib­ing prac­tices

6 months ago
Startups
Health Tech

Zealand’s ‘as­pi­ra­tional’ mis­sion for its amylin drug to be first-line in obe­si­ty

6 months ago
R&D

Up­dat­ed: Ver­tex makes mon­ey from gene-edit­ed ther­a­py Cas­gevy

6 months ago

FDA cites Mark Cuban's drug com­pound­ing cen­ter in Dal­las with steril­i­ty, qual­i­ty con­cerns

6 months ago
FDA+

The elec­tion is Tues­day. What’s at stake for the phar­ma in­dus­try?

6 months ago
FDA+

BioN­Tech eas­es 2024 rev­enue out­look de­spite hefty Covid vac­cine third-quar­ter sales

6 months ago

FDA ex­pands faster drug re­view pi­lot from sup­ple­men­tal to full ap­pli­ca­tions

6 months ago
FDA+

BioN­Tech says VEGF bis­pe­cif­ic’s PD-L1 tar­get, com­bo plans will be its edge

6 months ago
R&D

'We play to win': As­traZeneca de­tails first re­sults for oral GLP-1 and broad­er obe­si­ty am­bi­tions

6 months ago
R&D

Is there room for MASH drugs in a GLP-1 world?

6 months ago
R&D
In Focus

Viking's oral weight loss drug ap­pears to have strong ef­fect in Phase 1 tri­al

6 months ago
R&D

No­vo adds to We­govy’s car­dio strength with hos­pi­tal ad­mis­sions analy­sis

6 months ago

BMS, J&J and As­traZeneca plea with ap­peals court to over­turn drug price ne­go­ti­a­tions

6 months ago
Law

Her­itage and Apo­tex to pay $49.1M in price-fix­ing set­tle­ment

6 months ago
Law

Q&A with Obe­si­ty So­ci­ety’s CEO as the field pre­pares for next-gen meds

7 months ago

Te­va fined €462.6M by Eu­ro­pean reg­u­la­tors over Co­pax­one patent and com­pe­ti­tion al­le­ga­tions

7 months ago
Law

Fed­er­al court backs FDA's ap­proval of com­peti­tor to Jaz­z's sleep drug

7 months ago
FDA+
Law

‘Im­i­ta­tion is best form of flat­tery’: Re­gen­eron CEO com­ments on Am­gen’s Eylea biosim­i­lar

7 months ago
R&D

Gar­dasil de­mand in Chi­na sinks, and Mer­ck ex­pects the same next quar­ter

7 months ago
China
First page Previous page 27282930313233 Next page Last page
A service from the Financial Times